Helius Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Helius Medical Technologies
HSDT Stock  USD 3.13  0.26  7.67%   
Analyzing historical trends in various income statement and balance sheet accounts from Helius Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Helius Medical's valuation are summarized below:
Gross Profit
467 K
Market Capitalization
140 M
Enterprise Value Revenue
145.8913
Revenue
941 K
Earnings Share
(829.83)
There are currently one hundred twenty fundamental trends for Helius Medical Techn that can be evaluated and compared over time across competitors. All traders should confirm Helius Medical's regular fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 1.2 B in 2026. Enterprise Value is likely to drop to about 1.5 B in 2026

Helius Medical Total Revenue

468,234

Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 18.6 K, Selling General Administrative of 9.7 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 2.9 K, Dividend Yield of 0.0 or PTB Ratio of 1.2 K. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Build AI portfolio with Helius Stock
Check out the analysis of Helius Medical Correlation against competitors.

Helius Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding4.4 K4.2 K795
Slightly volatile
Total Assets3.9 M4.1 M6.6 M
Slightly volatile
Short and Long Term Debt Total10.3 K10.8 K328.7 K
Slightly volatile
Other Current Liabilities1.1 M1.1 M2.8 M
Very volatile
Total Current Liabilities3.6 M1.9 M3.6 M
Pretty Stable
Accounts Payable1.1 M785.7 K1.2 M
Very volatile
Cash1.2 M1.3 M4.7 M
Pretty Stable
Cash And Short Term Investments1.2 M1.3 M4.7 M
Pretty Stable
Net Receivables409.3 K730.2 K331.2 K
Slightly volatile
Common Stock Total Equity8559007.3 M
Pretty Stable
Liabilities And Stockholders Equity3.9 M4.1 M6.6 M
Slightly volatile
Other Current Assets808.9 K701.5 K660.8 K
Slightly volatile
Other Stockholder Equity208.2 M198.3 M84.9 M
Slightly volatile
Total Liabilities2.7 M2.9 M4.6 M
Pretty Stable
Short and Long Term Debt11.6 M11 M6.7 M
Slightly volatile
Total Current Assets3.7 M3.9 M6.1 M
Slightly volatile
Short Term Debt10.3 K10.8 K1.8 M
Pretty Stable
Common Stock3.4 K3.6 K6.9 M
Pretty Stable
Other Liabilities8.6 M8.2 M2.9 M
Slightly volatile
Long Term Debt1.8 M2 M1.7 M
Slightly volatile
Short Term Investments302.4 K340.2 K371.3 K
Slightly volatile
Non Current Liabilities Total349.6 K368 K1.8 M
Very volatile
Capital Surpluse149.6 M142.5 M68 M
Slightly volatile
Deferred Long Term Liabilities1.8 M2 M1.7 M
Slightly volatile
Property Plant And Equipment Net100.9 K106.2 K305.6 K
Pretty Stable
Current Deferred Revenue33.3 K35.1 K195.9 K
Slightly volatile
Other Assets0.860.927.9 K
Pretty Stable
Property Plant And Equipment Gross453.1 K461.7 K391.6 K
Slightly volatile
Property Plant Equipment612.1 K517.5 K387 K
Slightly volatile
Inventory1.3 M1.3 M570.6 K
Slightly volatile
Capital Stock3.4 K3.6 K18.2 K
Slightly volatile
Capital Lease Obligations10.3 K10.8 K392 K
Slightly volatile
Non Current Liabilities Other384.8 K226.8 K527.7 K
Slightly volatile
Intangible Assets20.5 K21.6 K406.5 K
Slightly volatile

Helius Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.7 M10.9 M8.5 M
Slightly volatile
Other Operating Expenses16.1 M16.6 M14.1 M
Slightly volatile
Research Development5.9 M4.2 M5.2 M
Very volatile
Total Operating Expenses15.8 M15.9 M13.9 M
Slightly volatile
Non Recurring1.8 M1.7 M1.2 M
Slightly volatile
Depreciation And Amortization51.3 K54 K311.6 K
Very volatile
Selling And Marketing Expenses570.2 K585.9 K678.7 K
Slightly volatile
Reconciled Depreciation65.5 K69 K99.9 K
Slightly volatile

Helius Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation2.5 M2.3 M3.7 M
Slightly volatile
Capital Expenditures4.3 K4.5 K913.7 K
Pretty Stable
Total Cash From Financing Activities12.5 M8 M9.9 M
Slightly volatile
End Period Cash Flow1.2 M1.3 M4.7 M
Pretty Stable
Sale Purchase Of Stock14.5 M11.1 M11.1 M
Pretty Stable
Begin Period Cash Flow6.8 M6 M5.1 M
Slightly volatile
Depreciation65.5 K69 K108.3 K
Slightly volatile
Issuance Of Capital Stock2.5 M2.7 M24.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.9 K3 K354.1 K
Slightly volatile
Days Sales Outstanding421401242
Slightly volatile
Average Payables86.4 K97.2 K106.1 K
Slightly volatile
Capex To Depreciation0.0910.09585.8297
Slightly volatile
EV To Sales2.9 K3 K354.1 K
Slightly volatile
Inventory Turnover1.080.650.5757
Slightly volatile
Days Of Inventory On Hand7607471.5 K
Slightly volatile
Payables Turnover0.430.60.3191
Slightly volatile
Sales General And Administrative To Revenue14.5716.3917.8851
Slightly volatile
Research And Ddevelopement To Revenue9.688.0914.4542
Slightly volatile
Capex To Revenue0.01050.01110.5157
Slightly volatile
Cash Per Share0.440.46134
Very volatile
Days Payables Outstanding59863036.3 K
Slightly volatile
Income Quality0.690.850.7401
Slightly volatile
Intangibles To Total Assets0.00340.00360.1211
Slightly volatile
Current Ratio2.021.421.9545
Slightly volatile
Receivables Turnover0.890.941.7152
Slightly volatile
Capex Per Share0.0020.002161.925
Pretty Stable
Average Receivables192.8 K183.6 K143.4 K
Slightly volatile
Revenue Per Share0.210.2213.9176
Slightly volatile
Interest Debt Per Share0.01170.0123196
Slightly volatile
Debt To Assets0.00370.00390.2981
Slightly volatile
Operating Cycle1 K1.3 K1.8 K
Slightly volatile
Price Earnings To Growth Ratio3.133.29192
Slightly volatile
Days Of Payables Outstanding59863036.3 K
Slightly volatile
Ebt Per Ebit0.990.970.9475
Pretty Stable
Total Debt To Capitalization0.01220.01290.9059
Slightly volatile
Quick Ratio1.90.991.8317
Slightly volatile
Cash Ratio0.430.451.3066
Slightly volatile
Days Of Inventory Outstanding7607471.5 K
Slightly volatile
Days Of Sales Outstanding421401242
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0205
Slightly volatile
Fixed Asset Turnover4.163.971.6735
Slightly volatile
Debt Ratio0.00370.00390.2981
Slightly volatile
Price Sales Ratio2.9 K3 K354.1 K
Slightly volatile
Asset Turnover0.140.130.0578
Slightly volatile

Helius Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.2 B1.2 B15.1 B
Pretty Stable
Enterprise Value1.5 B1.6 B15.1 B
Pretty Stable

Helius Fundamental Market Drivers

Helius Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue35.1 K33.3 K
Total Revenue598 K468.2 K
Cost Of Revenue669.3 K351.5 K
Sales General And Administrative To Revenue 16.39  14.57 
Research And Ddevelopement To Revenue 8.09  9.68 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.22  0.21 
Ebit Per Revenue(24.06)(25.27)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY